Sangamo Therapeutics Inc (NASDAQ:SGMO)

3.51
Delayed Data
As of Feb 03
 -0.16 / -4.36%
Today’s Change
2.72
Today|||52-Week Range
6.42
+11.78%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close3.67
Today’s open3.59
Day’s range3.50 - 3.68
Volume1,104,840
Average volume (3 months)1,329,976
Market cap$575.2M
Data as of 3:59pm ET, 02/03/2023

Growth & Valuation

Earnings growth (last year)-37.04%
Earnings growth (this year)-5.54%
Earnings growth (next 5 years)-1.00%
Revenue growth (last year)-6.34%
P/E ratioNM
Price/Sales9.79
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.09+3.00%
NSTGNanoString Technolog...-0.49-3.90%
BNGOBionano Genomics Inc-0.10-5.08%
----
Data as of 4:00pm ET, 02/03/2023

Financials

Next reporting dateMarch 2, 2023
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$110.7M
Annual profit (last year)-$178.3M
Net profit margin-161.05%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Brisbane, California

Forecasts